Biokin Pharmaceutical is a biopharmaceutical company dedicated to the forefront of global biomedical innovation, with a strategic focus on addressing unmet clinical needs. The company has established world-leading capabilities in large-molecule oncology therapeutics (ADC/GNC/ARC), encompassing cutting-edge research and development, global clinical development, and large-scale manufacturing and supply. Biokin is steadily advancing toward becoming a fully integrated multinational biopharmaceutical enterprise with global commercialization capabilities.

Nationally Certified " National High-tech Enterprise " , " The National Enterprise Technology Center " , " Exemplar IP Generating Entity " and Provincially Certified " Technological Innovation Exemplar Entity by .Sichuan Province
Received national, provincial, and city levelgrants for development efforts

As a global MNC focused on innovative tumor treatments, we possess a powerful R&D platform for sustainable innovation, an efficient operational platform, and numerous gold-standard drugs. We have earned widespread praise, long-term trust from doctors and patients, and widespread respect in the industry.

Mission:We strive for breakthrough innovations to achieve breakthrough therapies, aspiring to continuously bring more survival opportunities to every cancer patient worldwide until the end of their natural lifespan.